CANADA CLINICAL NUTRITION MARKET ANALYSIS

Market Challenges And Opportunities

Canada Clinical Nutrition Market– Drivers

• Increasing Awareness about the Nutrition Among Canadian Population: Due to the increase in awareness about nutrition among the Canadian population, there has been a growing demand for clinical nutrition among the population. This is expected to drive the growth of the Canada clinical nutrition market over the forecast period. For instance, since COVID-19 pandemic, awareness about the importance of proper nutrition and its impact on health has grown significantly among Canadians. More patients and healthcare providers now recognize that dietary modifications and nutrition interventions play a crucial role in treatment and management of chronic diseases. This growing recognition has fueled greater demand for specialized clinical nutrition products and services. For example, according to the research article published in the journal Healthcare 2022, as per the survey carried out by Dietitians of Canada, in the year 2021, it was found that over 80% of Canadians believe nutrition is important for disease prevention and management, compared to just 60% five years ago. As knowledge increases, consumers and doctors are more willing to utilize personalized nutritional therapies for conditions like diabetes, obesity, cardiovascular issues, and gastrointestinal disorders.
• Increasing Acquisition by the Market Players: Market players are focused on inorganic growth strategies, such as signing acquisition agreements, in order to expand its product portfolio and geographical presence in the market. In February 2022, Nestle Health Science, a provider of nutrition-based products, acquired Orgain Company, a plant-based nutrition-based company. In this agreement, Nestle would be able to expand the reach of the company Orgain Nutrition Products i.e. plant-based nutrition products, worldwide.

Canada Clinical Nutrition Market– Restraints

• Availability of stringent regulations in Canada is expected to restrain the Canada clinical nutrition market, over the forecast period. The clinical nutrition market in Canada is highly regulated by Health Canada, which ensures the safety and efficacy of nutrition products through a rigorous review and approval process for new entrants. Any small formulation changes to existing products also require re-approval. This stringent regulatory framework acts as a deterrent for smaller companies with limited resources to invest in clinical trials and navigate the complex approval process, which can take 1-2 years. The compliance burden and longer time-to-market delays restrain innovation and new product development in the Canada clinical nutrition market. In conclusion, while the aging population and rising chronic disease prevalence are driving demand growth factors, constraints around the high costs of products and stringent regulations present challenges to revenue and volume expansion in Canada’s clinical nutrition market. Innovation in formulations and manufacturing efficiencies will be key for companies to overcome pricing restraints.